Desert Company's Pharmaceutical Division incurred $840,000 of research and development costs to develop a new drug for which they were granted a patent on January 5, 2018. Legal fees and other costs associated with registration of the patent totaled $160,000. On March 10, 2020, Desert paid $350,000 for legal fees in a successful defense of the patent. The total amount capitalized for the patent through March 10, 2020, should be